دورية أكاديمية
أعرض في EDS

Polidocanol-foam treatment of varicose veins: Quality-of-life impact compared to conventional surgery.

التفاصيل البيبلوغرافية
العنوان: Polidocanol-foam treatment of varicose veins: Quality-of-life impact compared to conventional surgery.
المؤلفون: Sakugawa LS; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil., Portela FSO; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil. Electronic address: fsoaresportela@gmail.com., Louzada ACS; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil., Portugal MFC; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil., Teivelis MP; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil; Faculdade Israelita de Ciências da Saúde Albert Einstein, São Paulo, SP, Brazil., Mendes CA; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil., Pinheiro LL; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil; Faculdade Israelita de Ciências da Saúde Albert Einstein, São Paulo, SP, Brazil., Silva MFAD; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil., Fioranelli A; Santa Casa de Misericórdia de São Paulo, São Paulo, SP, Brazil., Wolosker N; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil; Faculdade Israelita de Ciências da Saúde Albert Einstein, São Paulo, SP, Brazil.
المصدر: Clinics (Sao Paulo, Brazil) [Clinics (Sao Paulo)] 2024 Apr 03; Vol. 79, pp. 100346. Date of Electronic Publication: 2024 Apr 03 (Print Publication: 2024).
نوع المنشور: Observational Study; Journal Article
اللغة: English
بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101244734 Publication Model: eCollection Cited Medium: Internet ISSN: 1980-5322 (Electronic) Linking ISSN: 18075932 NLM ISO Abbreviation: Clinics (Sao Paulo) Subsets: MEDLINE
أسماء مطبوعة: Publication: 2022- : [New York] : Elsevier
Original Publication: São Paulo, SP : Hospital das Clínicas, Faculty of Medicine, University of São Paulo, [2005]-
مواضيع طبية MeSH: Quality of Life* , Varicose Veins*/surgery , Varicose Veins*/therapy, Humans ; Polidocanol ; Polyethylene Glycols ; Prospective Studies ; Saphenous Vein ; Sclerosing Solutions/therapeutic use ; Sclerosing Solutions/adverse effects ; Sclerotherapy/adverse effects ; Treatment Outcome
مستخلص: Background and Objective: Lower limb varicose veins are a prevalent disease associated with several available treatment options, including conventional surgery and polidocanol foam sclerotherapy. However, few studies have analyzed therapeutic modality outcomes based on Patient-Reported Outcome Measures (PROMs). This large sample-size study was designed to evaluate the outcomes of polidocanol foam sclerotherapy compared to conventional surgery based on an analysis of PROMs.
Methods: This was a prospective, observational, and qualitative study of 205 patients who underwent varicose vein treatment with either polidocanol foam sclerotherapy (57 patients, 90 legs) or conventional surgery (148 patients, 236 legs). Patients were preoperatively assessed and re-evaluated 30 days after the procedure using the Venous Disease Severity Score (VCSS) and specific venous disease quality-of-life questionnaires (VEINES-QoL/Sym).
Results: Both treatments significantly improved VCSS and VEINES results 30 days after the procedure (p < 0.05). However, surgery promoted greater improvements in VCSS (on average 4.02-points improvement, p < 0.001), VEINES-QoL (average 8-points improvement, p < 0.001), and VEINES-Sym (average 11.66 points improvement, p < 0.001) than did sclerotherapy. Postoperative pain and aesthetic concerns about the legs were the domains of the questionnaires in which the results varied the most between the treatment modalities, with worse results for sclerotherapy.
Conclusion: Both polidocanol foam sclerotherapy and conventional surgery positively impact patients' quality of life after 30 days, but the improvement is more significant for patients who undergo conventional surgery.
Competing Interests: Conflicts of interest The authors declare no conflicts of interest.
(Copyright © 2024 HCFMUSP. Published by Elsevier España, S.L.U. All rights reserved.)
References: Ann Epidemiol. 2005 Mar;15(3):175-84. (PMID: 15723761)
J Vasc Surg Venous Lymphat Disord. 2015 Jul;3(3):333-40. (PMID: 26992316)
Br J Surg. 2012 Aug;99(8):1062-70. (PMID: 22627969)
Br J Surg. 2017 Oct;104(11):1424-1432. (PMID: 28771700)
J Vasc Surg. 2003 Feb;37(2):410-9. (PMID: 12563215)
J Vasc Surg Venous Lymphat Disord. 2015 Oct;3(4):456-460. (PMID: 26992626)
Rev Assoc Med Bras (1992). 2022 Nov 25;68(12):1657-1662. (PMID: 36449789)
Phlebology. 2021 May;36(4):283-289. (PMID: 33176592)
Ann Vasc Surg. 2022 Mar;80:60-69. (PMID: 34780949)
Int Angiol. 2017 Jun;36(3):281-288. (PMID: 28217989)
Medicine (Baltimore). 2021 May 21;100(20):e25921. (PMID: 34011062)
J Vasc Surg Venous Lymphat Disord. 2023 Mar;11(2):231-261.e6. (PMID: 36326210)
Cochrane Database Syst Rev. 2021 Dec 10;12:CD001732. (PMID: 34883526)
J Vasc Surg. 2000 Jun;31(6):1307-12. (PMID: 10842165)
Ann Vasc Surg. 2013 Jul;27(5):571-6. (PMID: 23540674)
Cochrane Database Syst Rev. 2021 Aug 11;8:CD005624. (PMID: 34378180)
Br J Surg. 2011 Aug;98(8):1079-87. (PMID: 21725957)
BMC Cardiovasc Disord. 2015 Aug 11;15:85. (PMID: 26260973)
Ann Vasc Surg. 2022 May;82:7-12. (PMID: 34933109)
Clinics (Sao Paulo). 2016 Nov 01;71(11):650-656. (PMID: 27982166)
Eur J Vasc Endovasc Surg. 2012 Sep;44(3):341-4. (PMID: 22831872)
J Patient Rep Outcomes. 2021 Oct 12;5(Suppl 2):99. (PMID: 34637010)
Phlebology. 2018 Aug;33(7):439-450. (PMID: 28720052)
Health Expect. 2021 Aug;24(4):1015-1024. (PMID: 33949755)
Ann Vasc Surg. 2022 May;82:1-6. (PMID: 34942339)
J Vasc Surg Venous Lymphat Disord. 2021 Jul;9(4):1031-1040. (PMID: 34144767)
Phlebology. 2017 Apr;32(3):185-193. (PMID: 27013511)
Phlebology. 2018 Mar;33(2):115-121. (PMID: 28081661)
Ann Vasc Surg. 2015 Aug;29(6):1128-35. (PMID: 26004968)
J Vasc Surg. 2011 Feb;53(2):374-82. (PMID: 21129895)
Dermatol Surg. 2001 Jan;27(1):58-60. (PMID: 11231246)
Br J Surg. 2018 May;105(6):692-698. (PMID: 29652081)
Rev Assoc Med Bras (1992). 2018 Aug;64(8):729-735. (PMID: 30673044)
J Vasc Surg. 2013 Sep;58(3):727-34.e1. (PMID: 23769603)
فهرسة مساهمة: Keywords: Polidocanol; Quality of life; Saphenous vein; Sclerotherapy; Varicose veins
المشرفين على المادة: 3055-99-0 (dodecylnonaoxyethylene glycol monoether)
0AWH8BFG9A (Polidocanol)
3WJQ0SDW1A (Polyethylene Glycols)
0 (Sclerosing Solutions)
تواريخ الأحداث: Date Created: 20240404 Date Completed: 20240410 Latest Revision: 20240425
رمز التحديث: 20240425
مُعرف محوري في PubMed: PMC11004700
DOI: 10.1016/j.clinsp.2024.100346
PMID: 38574572
قاعدة البيانات: MEDLINE
الوصف
تدمد:1980-5322
DOI:10.1016/j.clinsp.2024.100346